216 related articles for article (PubMed ID: 6704975)
1. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys.
Arndt CA; Colvin OM; Balis FM; Lester CM; Johnson G; Poplack DG
Cancer Res; 1987 Nov; 47(22):5932-4. PubMed ID: 3664493
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans.
Strong JM; Collins JM; Lester C; Poplack DG
Cancer Res; 1986 Dec; 46(12 Pt 1):6101-4. PubMed ID: 3096555
[TBL] [Abstract][Full Text] [Related]
4. Ability of a new antitumor agent, AZQ, to penetrate into cerebrospinal fluid.
Gormley PE; Wood JH; Poplack DG
Pharmacology; 1981; 22(3):196-8. PubMed ID: 7208602
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
Tan CT; Hancock CH; Mondora A; Hoffman NW
Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
[TBL] [Abstract][Full Text] [Related]
6. Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma and cerebrospinal fluid kinetics.
Bachur NR; Collins JM; Kelley JA; Van Echo DA; Kaplan RS; Whitacre M
Clin Pharmacol Ther; 1982 May; 31(5):650-5. PubMed ID: 7075113
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.
Schilsky RL; Kelley JA; Ihde DC; Howser DM; Cordes RS; Young RC
Cancer Res; 1982 Apr; 42(4):1582-6. PubMed ID: 7060028
[TBL] [Abstract][Full Text] [Related]
8. The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986).
Spiegel JF; Egorin MJ; Collins JM; Lerner BD; Bachur NR
Drug Metab Dispos; 1983; 11(1):41-6. PubMed ID: 6132794
[TBL] [Abstract][Full Text] [Related]
9. The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles.
Feun LG; Savaraj N; Lu K; Guo Z; Raulston LG; Benjamin RS; Fields WS; Loo TL
J Neurooncol; 1983; 1(3):219-24. PubMed ID: 6678971
[TBL] [Abstract][Full Text] [Related]
10. Phase I evaluation and pharmacokinetics of aziridinylbenzoquinone using a weekly intravenous schedule.
Schilcher RB; Young JD; Leichman LP; Haas CD; Baker LH
Cancer Res; 1983 Aug; 43(8):3907-11. PubMed ID: 6683127
[TBL] [Abstract][Full Text] [Related]
11. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.
Blaney SM; Cole DE; Balis FM; Godwin K; Poplack DG
Cancer Res; 1993 Feb; 53(4):725-7. PubMed ID: 8428353
[TBL] [Abstract][Full Text] [Related]
12. Decreased cytotoxicity of aziridinylbenzoquinone caused by polyamine depletion in 9L rat brain tumor cells in vitro.
Alhonen-Hongisto L; Deen DF; Marton LJ
Cancer Res; 1984 Jan; 44(1):39-42. PubMed ID: 6418379
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys.
Grygiel JJ; Balis FM; Collins JM; Lester CM; Poplack DG
Cancer Res; 1985 May; 45(5):2037-9. PubMed ID: 3986760
[TBL] [Abstract][Full Text] [Related]
14. The pharmacology of diaziquone given in intravenous or intracarotid infusion to normal and intracranial tumor-bearing puppies.
Egorin MJ; Bellis EH; Salcman M; Collins JM; Spiegel JF; Bachur NR
J Neurosurg; 1984 May; 60(5):1005-13. PubMed ID: 6716135
[TBL] [Abstract][Full Text] [Related]
15. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG
Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.
Blaney SM; Balis FM; Berg S; Arndt CA; Heideman R; Geyer JR; Packer R; Adamson PC; Jaeckle K; Klenke R; Aikin A; Murphy R; McCully C; Poplack DG
J Clin Oncol; 2005 Mar; 23(7):1555-63. PubMed ID: 15735131
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid and plasma pharmacokinetics of high doses of 1-beta-D-arabinofuranosylcytosine in nonhuman primates.
Lopez JA; Beardsley GP; Krikorian JG; Mortara RW; Agarwal RP
Cancer Res; 1983 Nov; 43(11):5190-3. PubMed ID: 6616454
[TBL] [Abstract][Full Text] [Related]
18. Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
Griffin JP; Newman RA; McCormack JJ; Krakoff IH
Cancer Treat Rep; 1982 Jun; 66(6):1321-5. PubMed ID: 7083235
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates.
Jackson DV; Castle MC; Poplack DG; Bender RA
Cancer Res; 1980 Mar; 40(3):722-4. PubMed ID: 7471091
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
Berg SL; Balis FM; Zimm S; Murphy RF; Holcenberg J; Sato J; Reaman G; Steinherz P; Gillespie A; Doherty K
J Clin Oncol; 1992 Jan; 10(1):143-8. PubMed ID: 1727916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
